Caelum Biosciences Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $69.9M
Latest Deal Amount
  • Investors
  • 2

Caelum Biosciences General Information

Description

Operator of a clinical-stage biotechnology comapny intended to develop treatments for rare and life-threatening conditions. The company is engaged in development of antibodies that work to break up pre-existing amyloid in tissues and to help the body's immune system remove the deleterious material, enabling patients with a greater chance to be a safe, receive well-tolerated therapy that promotes amyloid resolution and improve organ responses.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Rutgers Ecocomplex
  • 1200 Florence Road
  • Bordentown, NJ 08505
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Caelum Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 30-Jan-2019 $69.9M 000.00 Completed Clinical Trials - Phase 3
To view Caelum Biosciences’s complete valuation and funding history, request access »

Caelum Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a clinical-stage biotechnology comapny intended to develop treatments for rare and life-threatening conditio
Biotechnology
Bordentown, NJ
000.00
0000000000 0 000.00

000 0000

nim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequ
0000000000000
Ann Arbor, MI
0 As of 0000
000.00
00000000000 000.00

000000 0

re eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui offic
0000000000000
Williamsville, NY
00 As of 0000
00.000
000000000 - 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Caelum Biosciences Competitors (33)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ONL Therapeutics Venture Capital-Backed Ann Arbor, MI 0 000.00 00000000000 000.00
000000 00000000 Venture Capital-Backed Williamsville, NY 00 00.000 000000000 - 00.000
0000 0000 00000000 Formerly VC-backed Cambridge, MA 000 00000 00000000000 00000
0000000 0000000000 Formerly VC-backed La Jolla, CA 00 00000 00000000 00000
0000000 0000000000 Formerly PE-Backed Cambridge, MA 000 00000 000000000
You’re viewing 5 of 33 competitors. Get the full list »

Caelum Biosciences Executive Team (2)

Name Title Board Seat Contact Info
Michael Spector Chief Executive Officer, President & Board Member
Susan Sobolov Ph.D Chief Operating Officer
To view Caelum Biosciences’s complete executive team members history, request access »

Caelum Biosciences Board Members (12)

Name Representing Role Since
Harlan Weisman MD Self Board Member 000 0000
Lindsay Rosenwald MD Self Board Member 000 0000
Martin Goldman Caelum Biosciences Board Member 000 0000
Martine Zimmerman Caelum Biosciences Board Member 000 0000
Michael Spector Caelum Biosciences Chief Executive Officer, President & Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Caelum Biosciences Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alexion Corporation Minority 000 0000 000000 0
Columbia Technology Ventures University Minority 000 0000 000000 0
To view Caelum Biosciences’s complete investors history, request access »